# Use of TXA to Prevent Postpartum Hemorrhage

> **NCT03069859** · PHASE2 · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 31 (actual)

## Conditions studied

- Post Partum Hemorrhage

## Interventions

- **DRUG:** TXA (1g)
- **DRUG:** Placebo (0.9% saline)

## Key facts

- **NCT ID:** NCT03069859
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-06
- **Primary completion:** 2019-12-01
- **Final completion:** 2022-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03069859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03069859, "Use of TXA to Prevent Postpartum Hemorrhage". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03069859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*